TXNIP and early-onset autosomal dominant Alzheimer disease: For example, TXNIP-mediated redox inhibition is associated with the nervous system inflammation seen in Alzheimer’s disease, and also contributes to premature death of insulin-secreting cells in patients with diabetes.